Mon.Dec 16, 2024

article thumbnail

Ambulatory Care Pharmacists to Decrease PCP Workload, Increase Patient Access | ASHP Midyear

Drug Topics

Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.

98
article thumbnail

Viridian confirms benefit of drug for thyroid eye disease

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Fighting back a hyper 6-year-old and his 3-year-old partner in crime as I attempt to write an intro here. My offspring say hello.

97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Q&A: Educating Patients, Providers to Increase Biosimilar Implementation | ASHP Midyear

Drug Topics

Drug Topics met with Amanuel Kehasse, PharmD, PhD, to discuss the barriers surrounding biosimilar implementation in the prescription drug market.

98
article thumbnail

FDA Approves Tapinarof Cream 1% for Treatment of Atopic Dermatitis in Adults, Children 2 Years and Older

Pharmacy Times

The approval builds on previous indications for tapinarof, an aryl hydrocarbon receptor agonist, for the topical treatment of atopic dermatitis.

FDA 95
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Tapinarof Cream 1% Approved by FDA to Treat Atopic Dermatitis in Adults, Children 2 Years and Older

Drug Topics

Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.

FDA 98
article thumbnail

FDA Grants Breakthrough Therapy Designation to Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis

Pharmacy Times

Based on positive results from the HERCULES trial, the new designation will allow for more thorough regulatory review and development of the multiple sclerosis treatment.

FDA 91

More Trending

article thumbnail

Checkpoint Therapeutics takes on Merck's mighty Keytruda with FDA approval for Unloxcyt in skin cancer

Fierce Pharma

FDA 78
article thumbnail

Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear

Drug Topics

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

76
article thumbnail

SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes

Pharmacy Times

Obesity is associated with increased distant recurrence and breast cancer mortality in all types of early-stage breast cancer.

73
article thumbnail

Novo sets aside $1.2bn for rare diseases plant

pharmaphorum

73
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Dual-Targeted Therapy With Ruxolitinib and Duvelisib: Optimizing Treatment for T-Cell Lymphomas Through Pharmacist Collaboration

Pharmacy Times

Alison Moskowitz, MD, discusses the clinical considerations, dosing strategies, and the critical role of pharmacists in managing toxicities and tailoring treatment plans for dual-targeted therapy with ruxolitinib and duvelisib.

73
article thumbnail

2025 outlook: What's next for Medicare Advantage

Fierce Healthcare

72
article thumbnail

FDA clears Neurocrine drug for rare adrenal disorder

pharmaphorum

FDA 71
article thumbnail

Two Biomarkers Improve CRB-65 Predictability for Death Due to Community-Acquired Pneumonia

Pharmacy Times

The study authors add that the validation improved the risk score in additional community-acquired pneumonia cohorts, and clinical studies would assess the broad clinical applicability.

65
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio

Fierce Pharma

article thumbnail

IVIG Identified as a Treatment Marker of High Medical Costs, Resource Utilization in Patients With Myasthenia Gravis

Pharmacy Times

Often used as a treatment for severe exacerbations of myasthenia gravis, intravenous immunoglobulin can lead to high financial toxicity and resource utilization.

65
article thumbnail

STAT+: Pharmalittle: We’re reading about Novo Holdings proceeding with Catalent deal, Sanofi threatened with sanctions, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to nudge it in a better direction, we have planted ourselves in the Pharmalot cafeteria to quaff cups of stimulation.

article thumbnail

Nemolizumab Granted FDA Approval For Moderate-to-Severe Atopic Dermatitis

Pharmacy Times

Nemolizumab exclusively targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.

FDA 65
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New drugs 'benefit patients, but maybe not populations'

pharmaphorum

61
article thumbnail

Researchers Raise Questions About Low-Carb Diets and Effects on LDL Cholesterol

Pharmacy Times

Results of the study showed an inverse relationship between BMI and LDL cholesterol changes for those who adopt a low-carbohydrate diet.

65
article thumbnail

ADCs breach barriers to become mainstream cancer treatment

Pharmaceutical Technology

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

59
article thumbnail

ASHP Midyear: Overcoming Staffing Challenges and Ensuring Medication Access in Rural Pharmacies

Pharmacy Times

Rural pharmacies and hospitals face unique challenges in maintaining adequate staffing and drug supply inventory to serve patients who often travel long distance.

article thumbnail

Novo Nordisk blueprints $1.2B rare disease production plant in Denmark, where it plans to hire on 400 new staffers

Fierce Pharma

58
article thumbnail

Managing CRS and ICANS: Approaches and Protocols

Pharmacy Times

Panelists discuss how clinical management of CAR T-cell therapyassociated toxicities focuses primarily on early recognition and prompt intervention with tocilizumab and/or corticosteroids for cytokine release syndrome (CRS) and immune effector cellassociated neurotoxicity syndrome (ICANS), following established grading systems and treatment algorithms.

article thumbnail

Can you eat oranges if you have diabetes?

The Checkup by Singlecare

Theres nothing like biting into a sun-kissed orange, its juice filling your mouth with the refreshing taste of citrus. But if youre a person living with diabetes , you may wonder what effect the sweet treat will have on your blood sugar. You probably know that managing your blood sugar levels means being mindful of your carbohydrate intake and the glycemic index of your foods.

article thumbnail

Preventing CRS and ICANS Across Sites of Care

Pharmacy Times

Panelists discuss understanding institutional protocols for managing cytokine release syndrome (CRS) and immune effector cellassociated neurotoxicity syndrome (ICANS) prophylaxis in bispecific antibody therapy, along with criteria for safely selecting patients for outpatient step-up dosing.

article thumbnail

Neurocrine's Crenessity ends 70-year drought with FDA nod for rare genetic disease

Fierce Pharma

FDA 55
article thumbnail

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

Pharma Mirror

CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased deal-making on site. The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharma Mirror Magazine.

52
article thumbnail

The Benefits of Bioidentical Hormone Replacement Therapy (BHRT)

Compounding Pharmacy of America

Discover the benefits of BHRT, a natural solution for hormone imbalance. Learn how it relieves menopause symptoms, improves energy, and supports overall health. The post The Benefits of Bioidentical Hormone Replacement Therapy (BHRT) appeared first on Compounding Pharmacy of America.

article thumbnail

Trade & Channel Strategies 2024: A GTN Bubble Balancing Act

Pharmaceutical Commerce

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.

52
article thumbnail

A Guide to Compounded Prescriptions for Sports Medicine

Compounding Pharmacy of America

Discover how compounding for sports medicine provides athletes with personalized treatments for pain relief, recovery, and performance enhancement. The post A Guide to Compounded Prescriptions for Sports Medicine appeared first on Compounding Pharmacy of America.

article thumbnail

A Rocky Road for Regulation

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Trade & Channel Strategies 2024: The Role of Patient Service Teams in Driving Direct-to-Patient Adherence

Pharmaceutical Commerce

Kevin OMeara discusses how patient service teams influence adherence from Direct-to-Patient models.

52